PNAA
ABBV icon

Pictet North America Advisors’s AbbVie ABBV Stock Holding History

Pictet North America Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,932
Closed -$1.44M – 140
2024
Q1 		$1.44M Buy
+7,932
New +$1.37M 0.16% 83
2020
Q4 		– Sell
-30,047
Closed -$2.63M – 124
2020
Q3 		$2.63M Buy
30,047
+425
+1% +$40K 0.37% 43
2020
Q2 		$2.91M Buy
29,622
+3,035
+11% +$267K 0.42% 43
2020
Q1 		$2.03M Buy
26,587
+5,181
+24% +$441K 0.35% 50
2019
Q4 		$1.9M Sell
21,406
-190
-0.9% -$15.8K 0.23% 63
2019
Q3 		$1.64M Buy
21,596
+6,935
+47% +$475K 0.22% 67
2019
Q2 		$1.07M Buy
14,661
+9,314
+174% +$732K 0.16% 81
2019
Q1 		$431K Buy
5,347
+26
+0.5% +$2.13K 0.06% 116
2018
Q4 		$491K Hold
5,321
– – 0.04% 113
2018
Q3 		$503K Buy
5,321
+144
+3% +$13.7K 0.07% 124
2018
Q2 		$480K Hold
5,177
– – 0.07% 93
2018
Q1 		$490K Hold
5,177
– – 0.07% 93
2017
Q4 		$501K Buy
5,177
+1,411
+37% +$133K 0.08% 90
2017
Q3 		$335K Hold
3,766
– – 0.05% 104
2017
Q2 		$273K Sell
3,766
-361
-9% -$24.3K 0.05% 115
2017
Q1 		$269K Buy
4,127
+361
+10% +$22.7K 0.04% 114
2016
Q4 		$236K Sell
3,766
-21,941
-85% -$1.34M 0.05% 98
2016
Q3 		$1.62M Buy
25,707
+213
+0.8% +$13.8K 0.39% 43
2016
Q2 		$1.58M Buy
25,494
+4,104
+19% +$250K 0.37% 42
2016
Q1 		$1.22M Buy
21,390
+4,189
+24% +$233K 0.26% 47
2015
Q4 		$1.02M Sell
17,201
-1,095
-6% -$63.1K 0.24% 44
2015
Q3 		$995K Sell
18,296
-560
-3% -$36.5K 0.28% 34
2015
Q2 		$1.27M Sell
18,856
-2,700
-13% -$176K 0.45% 18
2015
Q1 		$1.26M Sell
21,556
-390
-2% -$23.6K 0.24% 34
2014
Q4 		$1.44M Buy
+21,946
New +$1.38M 0.29% 31

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pictet North America Advisors's ABBV Position: Q2 2024 in Review

Pictet North America Advisors sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 7,932 shares — an estimated $1.44M sold.

Pictet North America Advisors first reported a position in ABBV in Q4 2014 and held it in 25 quarters. The position peaked at $2.91M in Q2 2020. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Pictet North America Advisors reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Pictet North America Advisors sold 7,932 AbbVie shares in Q2 2024, an estimated $1.44M.
  • Pictet North America Advisors first reported a position in AbbVie in Q4 2014 and held it in 25 quarters.
  • Pictet North America Advisors's AbbVie position peaked at $2.91M in Q2 2020.
  • 3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Pictet North America Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.